Ani pharmaceuticals provides preliminary fourth quarter and 2024 financial results and preliminary 2025 outlook

Baudette, minn., jan. 13, 2025 (globe newswire) -- ani pharmaceuticals, inc. (nasdaq: anip) (ani or the company) today affirmed its prior net revenues, adjusted non-gaap ebitda, and adjusted non-gaap diluted eps guidance for 2024 and provided its preliminary financial outlook for 2025. nikhil lalwani, ani's president and chief executive officer, will discuss these updates as part of a presentation at the 43rd annual j.p. morgan healthcare conference on tuesday, january 14, 2025, at 2:15 pst/5:15 est.
ANIP Ratings Summary
ANIP Quant Ranking